“Application of the ultra micro analytical system (SUMA) technology for the detection of urinary hCG in antidoping control”

References

• Barroso, O.; Mazzoni, I.; Rabin, O. Review Hormone Abuse in Sports: The Antidoping Perspective. Asian J. Androl. 2008, 10(3), 391–402. DOI: 10.1111/j.1745-7262.2008.00332.x.
   PubMed Web of Science ®Google Scholar
• Cole, L. A.;. Human Chorionic Gonadotropin (Hcg) and Hyperglycosylated hCG, Seven Semi-Independent Critical Molecules: A Review. J Mol Oncol Res. 2017, 1(1), 22–24.
   Google Scholar
• Cole, L. A.;. Familial hCG Syndrome. J. Reprod. Immunol. 2012, 93, 52–57. DOI: 10.1016/j.jri.2011.11.001.
   PubMed Web of Science ®Google Scholar
• Iles, R. K.; Purkis, P. E.; Whitehead, Oliver, R. T. D.; Leigh, I.; Chard, T. Expression of Beta Human Chorionic Gonadotrophin by Non-Trophoblastic Non-Endocrine ‘Normal’ and Malignant Epithelial Cells. Br. J. Cancer. 1990, 61, 663–666.
   PubMed Web of Science ®Google Scholar
• The World Anti-Doping Code. International Standard. Prohibited List, January 2018. Available in https://www.wada-ama.org/en/what-we-do/international-standards. March 20, 2018.
   Google Scholar
• Cole, L. A.;. hCG Structure: A Logical Perspective. Asian Pac. J. Reprod. 2012, 1(4), 287–292. DOI: 10.1016/S2305-0500(13)60094-9.
   Google Scholar
• Strahm, E.; Marques-Vidal, P.; Pralong, F.; Dvorak, J.; Saugy, M.; Baume, N. Influence of Multiple Injections of Human Chorionic Gonadotropin (Hcg) on Urine and Serum Endogenous Steroids Concentrations. Forensic Sci. Int. 2011, 213(1–3), 62–72. DOI: 10.1016/j.forsciint.2011.07.002.
   PubMed Web of Science ®Google Scholar
• Stenman, U. H.; Hotakainen, K.; Alfthan, H. REVIEW Gonadotropins in Doping: Pharmacological Basis and Detection of Illicit Use. Br. J. Pharmacol. 2008, 154, 569–583. DOI: 10.1038/bjp.2008.102.
   PubMed Web of Science ®Google Scholar
• Tan, A.; Van der Merwe, A. M.; Low, X.; Chrystal, K. Case Report Familial HCG Syndrome: A Diagnostic Challenge. Gynecologic Oncol. Rep. 2014, 10, 47–48. DOI: 10.1016/j.gynor.2014.05.005.
   PubMedGoogle Scholar
• World Anti-Doping Agency. International Standard for Laboratories, Version 9.0 Valid Since 02 June 2016. Available in https://www.wada-ama.org/en/what-we-do/international-standards. on March 20, 2018
   Google Scholar
• World Anti-Doping Agency. Technical Document – TD2018CG/LH. Reporting & Management of Urinary Human Chorionic Gonadotrophin (Hcg) and Luteinizing Hormone (LH) Findings in Male Athletes. Available in https://www.wada-ama.org/en/what-we-do/international-standards. on March 20, 2018.
   Google Scholar
• González Reyes, E. C.; Castells, E. M.; Frómeta, A.; Arteaga, A. L.; Del Río, L.; Tejeda, Y.; Pérez, P. L.;; et al. SUMA Technology and Newborn Screening Tests for Inherited Metabolic Diseases in Cuba: An Overview of the First 30 Years. J Inborn Errors of Metabolism & Screening. 2016, 4, 1–9. DOI: 10.1177/2326409816661356.
   Google Scholar
• Castells, E. M.; Del Valle, R.; González, E. C.; Melchor, A.; Pérez, P. L.; González, I.; Carr, A.; León, K. An Enzyme Immunoassay for Determining Epidermal Growth Factor (EGF) in Human Serum Samples Using an Ultramicroanalytical System. J Immunoassay Immunochem. 2017, 38(2), 190–201. DOI: 10.1080/15321819.2016.1236729.
   PubMedGoogle Scholar
• Larsen, J.; Buchanan, P.; Johnson, S.; Godbert, S.; Zinaman, M. Human Chorionic Gonadotropin as a Measure of Pregnancy Duration. Int. J. Gynecol. Obstetrics. 2013, 123, 189–195. DOI: 10.1016/j.ijgo.2013.05.028.
   PubMed Web of Science ®Google Scholar
• Morse, B. A.; Sammel, M. D.; Shaunik, A.; Allen-Taylor, L.; Oberfoell, N.; Takacs, P.; Chung, K.; Barnhart, K. Performance of hCG Curves in Women at Risk for Ectopic Pregnancy: Exceptions to the Rules. Fertil. Steril. January 2012, 97(1), 101–106. DOI: 10.1016/j.fertnstert.2011.10.037.
   PubMed Web of Science ®Google Scholar
• Kingdom, J. P.; Kelly, T.; MacLean, B.; MacAllister, E. Rapid One Step Urine Test for Human Chorionic Gonadotrophin in Evaluating Suspected Complications of Early Pregnancy. Br Med J. 1991, 302, 1308–1311.
   PubMedGoogle Scholar
• Cole, L. A.; Khanlian, S. A.; Muller, C. Y.; Giddings, A.; Kohorn, E.; Berkowitz, R. Gestational Trophoblastic Diseases: 3. Human Chorionic Gonadotropin-Free β-subunit, a Reliable Marker of Placental Site Trophoblastic Tumors. Gynecol. Oncol. 2006, 102, 160–164. DOI: 10.1016/j.ygyno.2005.12.046.
   PubMed Web of Science ®Google Scholar
• Leman, E. S.; Gonzalgo, M. L. Prognostic Features and Markers for Testicular Cancer Management. Indian J. Urol. Jan-Mar 2010, 26(1), 76–81. DOI: 10.4103/0970-1591.60450.
   PubMedGoogle Scholar
• Yahong, L.; Xiaojuan, Z.; Sun, Y.; Dongyang, H.; Wang, Y.; Zhengfeng, X.; Tao, J. Combined Detection of α-fetoprotein and Free β-human Chorionic Gonadotropin in Screening for Trisomy 21 and Management of Cases in the Moderate Risk Value Range. Mol. Clin. Oncol. 2017, 3, 623–628.
   Google Scholar
• Cocchi, G.; Gualdi, S.; Bower, C.; Halliday, J.; Jonsson, B.; Myrelid, A.; Mastroiacovo, P.; Amar, E.; Bakker, M. K.; Correa, A.; Doray, B.;; et al. International Trends of down Syndrome 1993–2004: Births in Relation to Maternal Age and Terminations of Pregnancies. Birth Defects Res. 2010, 88, 474–479. DOI: 10.1002/bdra.20666.
   PubMed Web of Science ®Google Scholar
• Chan-Kyung, J. C.; Smith, C. R.; Diamandis, E. P. Amniotic Fluid Proteome Analysis from down Syndrome Pregnancies for Biomarker Discovery. J. Proteome Res. 2010, 9, 3574–3582. DOI: 10.1021/pr100088k.
   PubMed Web of Science ®Google Scholar
• UM HCG-UM2021. Centro de InmunoEnsayo. Updated May 2014. Version 3. Available in https://www.paho.org/cub/index.php?option=com_content&view=article&id=223:centro-inmunoensayo-cie&Itemid=528. Consulted on January 18, 2018.
   Google Scholar
• Ochoa Azze, R. F.; Bases metodológicas para la evaluación de anticuerpos de ensayos clínicos de vacunas mediante técnicas Inmunoenzimáticas. Finlay Edition, Second edition, 2008. Available in http://www.finlay.sld.cu/ediciones.htm. on January 18, 2018.
   Google Scholar
• Andreasson, U.; Perret-Liaudet, A.; Van Waalwijk Van Doorn, L.; Blennow, K.; Chiasserini, D.; Engelborghs, S.; Fladby, T.; Genc, S.; Kruse, N.; Bea Kuiperij, K.; Kulic, L.;, et al. A Practical Guide to Immunoassay Method Validation. Front Neurol. August 2015, 6, 179.DOI:10.3389/fneur.2015.00179.
   PubMed Web of Science ®Google Scholar
• Pérez, E.; Valderrama, S.; Baxera, A.; Jiménez, Y.; García, G.; Costa, L.; Quintana, M. Validación de un ELISA para la cuantificación de las impurezas proteicas de la cepa hospedera en el principio activo de la vacuna recombinante cubana contra la hepatitis B. VacciMonitor. 2014, 23(1), 11–16.
   Google Scholar
• Ellefsen, K. N.; Anizan, S.; Castaneto, M. S.; Desrosiers, N. A.; Martin, T. M.; Klette, K. L.; Huestis, M. A. Validation of the Only Commercially Available Immunoassay for Synthetic Cathinones in Urine: Randox Drugs of Abuse V Biochip Array Technology. Drug Test Anal. July 2014, 6, 728–738. DOI: 10.1002/dta.1633.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Pelier, C.; Chang-Monteagudo, A.; Zúñiga-Rosales, Y.; Torres-Rives, B.; Martínez-Tellez, G.; la Rosa-Hernández, D.; Martínez-Perera, A. Validación de un inmunoensayo tipo ELISA para la cuantificación de los niveles séricos de antígeno de superficie en pacientes con infección crónica por Virus de la Hepatitis B. Rev. Biomed. 2017, 28, 109–121.
   Google Scholar
• Carlos Pías, N.; Rego Díaz, A.; Fernández Yero, J. L.; Sistachs Vega, V. Tamiz perinatal en Cuba con procesamiento de datos mediante el uso de tecnología SUMA®. Biotecnología Aplicada. 2014, 31, 311–316.
   Google Scholar
• Tecnosuma Internacional, S. A.; Programas de Salud. Available in: www/cie.cu. (August 20, 2018).
   Google Scholar
• Castells, E. M.; González, E. C.; Pérez, P. L.; Del Río, L.; Tejeda, Y.; Perea, Y.; Martín, O.; Espinosa, M.; Rivero, J. A.; Frómeta, A. Evaluation of UMELISA® T4 Neonatal and UMELISA® T4 Using Polystyrene Plates Coated with Anti-Thyroxine (T4) Monoclonal Antibodies. J Immunoassay Immunochem, 08 Jan 2018, 32–40. DOI: 10.1080/15321819.2017.1392321.
   Google Scholar
• Frómeta, A.; González Reyes, E. C.; Castells, E.; Tejeda, Y.; Almenares, P.; Pérez, P. L. Quantitative Ultramicrotest for Newborn Screening of Galactosemia in Cuba. J. Perinat. Med. 2011, 39, 77–81. DOI: 10.1515/jpm.2010.135.
   PubMed Web of Science ®Google Scholar
• González, E. C.; Marrero, N.; Pérez, P. L.; Frómeta, A.; Zulueta, O.; Herrera, D.; Martínez, L.; Castells, E. An Enzyme Immunoassay for Determining 17α-hydroxyprogesterone in Dried Blood Spots on Filter Paper Using an Ultramicroanalytical System. Clinica Chimica Acta. 2008, 394, 63–66. DOI: 10.1016/j.cca.2008.04.004.
   PubMed Web of Science ®Google Scholar